Brief: Insilico Medicine Cayman TopCo Reports 2025 Revenue Of $56.2 Million
29/03/2026 12:43
March 29 (Reuters) - Insilico Medicine Cayman TopCo 3696.HK: 2025 REVENUE $56.2 MILLION Source text Further company coverage: 3696.HK (Reporting by Beijing Newsroom) ((yukun.zhang@thomsonreuters.com;))
Recent news on Insilico Medicine Cayman TopCo
See all newsInSilico Medicine jumps on progress in testing of new weight-loss drug
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7